Book a Meeting

Anti-SELL Antibody, Non-Fucosylated (BioBet-439ZP)

Cat#: BioBet-439ZP
Target: SELL
Isotype: IgG4
Host: Humanized
Species Reactivity: Human

Description Anti-SELL Antibody, Non-Fucosylated (BioBet-439ZP) is a humanized monoclonal IgG4 antibody against SELL. This product is an ADCC enhanced antibody produced by our Afuco™ platform.

Antibody Indication Unknown

Classification Therapeutic antibody; biobetter

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced SELL antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name SELL

Full Name Selectin L

Background This gene encodes a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors. The encoded protein contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. The gene product is required for binding and subsequent rolling of leucocytes on endothelial cells, facilitating their migration into secondary lymphoid organs and inflammation sites. Single-nucleotide polymorphisms in this gene have been associated with various diseases including immunoglobulin A nephropathy. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2009]

Alternative Names Aselizumab; 395639-53-9; HuDreg-55; HuEP5C7; SMART Anti-L Selectin; SELL; selectin L; LNHR, LYAM1, lymphocyte adhesion molecule 1; L-selectin; CD62L; hLHRc; LAM 1; LAM1; Leu 8; LSEL; Lyam 1; PLNHR; gp90-MEL; pln homing receptor; lymph node homing receptor

Gene ID 6402

UniProt ID P14151

Cellular Localization Plasma membrane

Involvement in Disease Diseases associated with SELL include Arthus Reaction and Cryptococcosis.

Related Pathways Its related pathways are Cell surface interactions at the vascular wall and Hematopoietic Stem Cells and Lineage-specific Markers.

Function Calcium-dependent lectin mediates cell adhesion by binding to glycoproteins on neighboring cells. It mediates the adhesion of lymphocytes to the endothelial cells of the surrounding lymph node high endothelial venules. Promote the initial aggregation and rolling of white blood cells in the endothelium.

Post-translational modifications 1.N-glycosylated 2.Glycosylation at Asn60, Asn104, Asn177, Asn232, Asn246, and Asn271 3.Ubiquitination at Lys78, Lys93, Lys134, Lys137, and Lys141 4.Modification sites at PhosphoSitePlus

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Isotype IgG4

Antibody Clone BioBet-439ZP

Description ADCC-enhanced Aselizumab is a non-fucosylated anti-SELL therapeutic biobetter antibody.

Antibody Indication Unknown

Unknown

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas